PubMed:23952588 / 380-498 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCoin-sentences

    {"project":"LitCoin-sentences","denotations":[{"id":"T6","span":{"begin":0,"end":118},"obj":"Sentence"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}

    LitCoin-entities

    {"project":"LitCoin-entities","denotations":[{"id":"9334","span":{"begin":45,"end":53},"obj":"OrganismTaxon"},{"id":"9335","span":{"begin":59,"end":61},"obj":"DiseaseOrPhenotypicFeature"},{"id":"9336","span":{"begin":79,"end":87},"obj":"ChemicalEntity"}],"attributes":[{"id":"A12","pred":"db_id","subj":"9334","obj":"NCBITaxon:9606"},{"id":"A13","pred":"db_id","subj":"9335","obj":"MESH:D010300"},{"id":"A14","pred":"db_id","subj":"9336","obj":"MESH:D007980"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}

    LitCoin-Disease-MeSH

    {"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T8","span":{"begin":59,"end":61},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"originalLabel","subj":"T8","obj":"D010300"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}

    LitCoin_Mondo_095

    {"project":"LitCoin_Mondo_095","denotations":[{"id":"T9","span":{"begin":59,"end":61},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0015873"},{"id":"A10","pred":"mondo_id","subj":"T9","obj":"0008199"},{"id":"A11","pred":"mondo_id","subj":"T9","obj":"0005180"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}

    LitCoin-MeSH-Disease-2

    {"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T8","span":{"begin":59,"end":61},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"ID:","subj":"T8","obj":"D010300"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}

    LitCoin-MONDO_bioort2019

    {"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T8","span":{"begin":59,"end":61},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"#label","subj":"T8","obj":"D010300"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}

    LitCoin-Chemical-MeSH-CHEBI

    {"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T4","span":{"begin":79,"end":87},"obj":"ChemicalEntity"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_15765"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}

    LitCoin-NCBITaxon-2

    {"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T2","span":{"begin":45,"end":53},"obj":"OrganismTaxon"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}

    LitCoin-training-merged

    {"project":"LitCoin-training-merged","denotations":[{"id":"T4","span":{"begin":79,"end":87},"obj":"ChemicalEntity"},{"id":"T37935","span":{"begin":59,"end":61},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T28904","span":{"begin":45,"end":53},"obj":"OrganismTaxon"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_15765"},{"id":"A99256","pred":"#label","subj":"T37935","obj":"D010300"}],"text":"This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months."}